You have 9 free searches left this month | for more free features.

Suberoylanilide Hydroxamic Acid

Showing 26 - 50 of 8,024

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage I Small Lymphocytic Lymphoma Trial in Seattle

Completed
  • Chronic Lymphocytic Leukemia
  • +8 more
  • Fludarabine Phosphate
  • +3 more
  • Seattle, Washington
  • +1 more
Feb 14, 2020

Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Seattle (drug, procedure, radiation, other)

Completed
  • Male Breast Cancer
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jan 2, 2020

Lymphoma Trial in Houston (Lenalidomide, Vorinostat, Gemcitabine)

Terminated
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 26, 2019

Liver Cancer Trial in Richmond (sorafenib tosylate, vorinostat)

Completed
  • Liver Cancer
  • Richmond, Virginia
  • +1 more
Aug 16, 2019

Acute Lymphoblastic Leukemia, Precursor B-Cell Lymphoblastic Leukemia, Precursor T-Cell Lymphoblastic Leukemia Trial in

Terminated
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Los Angeles, California
  • +27 more
Oct 5, 2020

AIDS-Related Plasmablastic Lymphoma, AIDS-Related Primary Effusion Lymphoma, Ann Arbor Stage I DLBCL Trial in United States

Completed
  • AIDS-Related Plasmablastic Lymphoma
  • +15 more
  • Montgomery, Alabama
  • +34 more
Feb 23, 2022

Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Seattle (drug, other, procedure, radiation,

Completed
  • Male Breast Cancer
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Aug 15, 2019

Multiple Myeloma Trial in Hackensack (Vorinostat, Lenalidomide, Carfilzomib, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Vorinostat, Lenalidomide, Carfilzomib, Dexamethasone
  • Hackensack, New Jersey
    Hackensack University Medical Center
Oct 4, 2021

Myelodysplastic Syndrome Trial in France (Azacitidine and oral vorinostat)

Terminated
  • Myelodysplastic Syndrome
  • Azacitidine and oral vorinostat
  • Angers, France
  • +23 more
May 24, 2019

Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Diffuse Intrinsic Pontine Glioma Trial in Australia, Canada, United States

Completed
  • Anaplastic Astrocytoma
  • +3 more
  • 3-Dimensional Conformal Radiation Therapy
  • +3 more
  • Birmingham, Alabama
  • +179 more
Oct 5, 2021

Adult DLBCL, B-Cell Non-Hodgkin Lymphoma, Follicular Lymphoma Trial in Seattle (Autologous Hematopoietic Stem Cell

Completed
  • Adult Diffuse Large B-Cell Lymphoma
  • +5 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Mar 3, 2020

Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx Trial in Columbus (drug,

Completed
  • Stage III Squamous Cell Carcinoma of the Oropharynx
  • Stage IV Squamous Cell Carcinoma of the Oropharynx
  • Columbus, Ohio
    The Ohio State University Comprehensive Cancer Center
Jun 3, 2019

Recurrent Aggressive Non-Hodgkin Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Burkitt Lymphoma Trial in Houston

Not yet recruiting
  • Recurrent Aggressive Non-Hodgkin Lymphoma
  • +6 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 6, 2020

Brain Stem Glioma, Cerebral Astrocytoma, Childhood Cerebellar Anaplastic Astrocytoma Trial in Canada, United States

Active, not recruiting
  • Brain Stem Glioma
  • +4 more
  • Bevacizumab
  • +2 more
  • Birmingham, Alabama
  • +136 more
Oct 15, 2022

Leukemia, Acute Myeloid Trial in Minneapolis, Milwaukee (Decitabine, Vorinostat, Fludarabine)

Terminated
  • Leukemia, Acute Myeloid
  • Minneapolis, Minnesota
  • +1 more
Jan 22, 2019

Ann Arbor Stage II Non-Hodgkin Lymphoma, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial

Active, not recruiting
  • Ann Arbor Stage II Non-Hodgkin Lymphoma
  • +2 more
  • Mobile, Alabama
  • +189 more
Jan 28, 2023

Acute Lymphoblastic Leukemia Trial in Canada, United States (ITMHA, Dexamethasone, Mitoxantrone)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • Los Angeles, California
  • +17 more
Jun 6, 2022

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +13 more
  • Stanford, California
  • +3 more
May 2, 2019

HIV Trial in Brighton, London (Combination Antiretroviral Therapy (cART), Raltegravir, Vorinostat)

Active, not recruiting
  • HIV
  • Combination Antiretroviral Therapy (cART)
  • +4 more
  • Brighton, United Kingdom
  • +5 more
Aug 24, 2021

Lymphoma Trial in Beverly Hills, Duarte, Pasadena (rituximab, vorinostat)

Completed
  • Lymphoma
  • Beverly Hills, California
  • +2 more
Jul 9, 2018

Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Canada, United

Active, not recruiting
  • Chronic Myelomonocytic Leukemia
  • +6 more
  • Birmingham, Alabama
  • +297 more
Jan 28, 2023

Recurrent NSCLC, Stage IIIB NSCLC, Stage IV NSCLC Trial in United States (vorinostat, laboratory biomarker analysis)

Completed
  • Recurrent Non-small Cell Lung Cancer
  • +2 more
  • Green Bay, Wisconsin
  • +4 more
Jan 3, 2018

Acute Myelogenous Leukemia Trial in Australia, Canada, United States (Decitabine, Vorinostat, Filgrastim (G-CSF))

Completed
  • Acute Myelogenous Leukemia
  • Los Angeles, California
  • +32 more
Jun 22, 2022

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Nodal Marginal Zone Lymphoma, Recurrent Grade 1

Completed
  • Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
  • +6 more
  • Duarte, California
  • +4 more
Feb 5, 2018